Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Sep 2026.
- Largest single sale: $507K (48,065 shares) of Alumis Inc. on Sep 8, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Alumis Inc. (ALMS) | Director | Jun 27, 2024 | Sep 9, 2026 |
| Mineralys Therapeutics, Inc. (MLYS) | Director | Feb 9, 2023 | Feb 20, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 8, 2026, Alumis Inc.: sold 48,065 shares for $507K, no plan disclosed; bought 273,290 shares for $2.9M (some held indirectly). 1 filing: 1
- Sep 4, 2026, Alumis Inc.: bought 220,070 shares for $2.5M (some held indirectly). 1 filing: 1
- Jun 30, 2026, Alumis Inc.: 3,553 shares granted. 1 filing: 1
- Feb 19, 2026, Mineralys Therapeutics, Inc.: 6,200 shares granted. 1 filing: 1
- Jan 9, 2026, Alumis Inc.: bought 588,235 shares for $10.0M (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.